NanoenTekInc (039860) - Net Assets
Based on the latest financial reports, NanoenTekInc (039860) has net assets worth ₩73.19 Billion KRW (≈ $49.60 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩78.61 Billion ≈ $53.27 Million USD) and total liabilities (₩5.42 Billion ≈ $3.68 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 039860 asset base for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩73.19 Billion |
| % of Total Assets | 93.1% |
| Annual Growth Rate | 7.02% |
| 5-Year Change | 62.67% |
| 10-Year Change | 92.65% |
| Growth Volatility | 23.22 |
NanoenTekInc - Net Assets Trend (2007–2024)
This chart illustrates how NanoenTekInc's net assets have evolved over time, based on quarterly financial data. Check tangible net worth ratio of NanoenTekInc to evaluate the tangible quality of the company's equity base.
Annual Net Assets for NanoenTekInc (2007–2024)
The table below shows the annual net assets of NanoenTekInc from 2007 to 2024. For live valuation and market cap data, see market value of NanoenTekInc.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩73.99 Billion ≈ $50.15 Million |
+38.07% |
| 2023-12-31 | ₩53.59 Billion ≈ $36.32 Million |
-7.04% |
| 2022-12-31 | ₩57.65 Billion ≈ $39.07 Million |
+10.14% |
| 2021-12-31 | ₩52.34 Billion ≈ $35.47 Million |
+15.07% |
| 2020-12-31 | ₩45.49 Billion ≈ $30.83 Million |
+10.87% |
| 2019-12-31 | ₩41.03 Billion ≈ $27.80 Million |
+16.71% |
| 2018-12-31 | ₩35.15 Billion ≈ $23.82 Million |
+48.12% |
| 2017-12-31 | ₩23.73 Billion ≈ $16.08 Million |
-7.22% |
| 2016-12-31 | ₩25.58 Billion ≈ $17.33 Million |
-33.41% |
| 2015-12-31 | ₩38.41 Billion ≈ $26.03 Million |
+8.19% |
| 2014-12-31 | ₩35.50 Billion ≈ $24.06 Million |
+50.57% |
| 2013-12-31 | ₩23.58 Billion ≈ $15.98 Million |
+2.62% |
| 2012-12-31 | ₩22.98 Billion ≈ $15.57 Million |
-20.08% |
| 2011-12-31 | ₩28.75 Billion ≈ $19.48 Million |
+23.11% |
| 2007-12-31 | ₩23.35 Billion ≈ $15.83 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to NanoenTekInc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2298174459000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩22.98 Billion | 31.06% |
| Common Stock | ₩16.06 Billion | 21.70% |
| Other Components | ₩34.96 Billion | 47.24% |
| Total Equity | ₩73.99 Billion | 100.00% |
NanoenTekInc Competitors by Market Cap
The table below lists competitors of NanoenTekInc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Brompton Lifeco Split Corp
TO:LCS
|
$76.07 Million |
|
Nasmedia Co. Ltd
KQ:089600
|
$76.08 Million |
|
Chuwa Wool Industry Co Taiwan Ltd
TW:1439
|
$76.09 Million |
|
Edisun Power Europe AG
SW:ESUN
|
$76.16 Million |
|
Northern Technologies
NASDAQ:NTIC
|
$76.03 Million |
|
Sea Oil Public Company Limited
BK:SEAOIL
|
$76.01 Million |
|
United U Li Corporation Bhd
KLSE:7133
|
$76.01 Million |
|
VenHub Global, Inc.
NASDAQ:VHUB
|
$75.97 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NanoenTekInc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 53,592,936,320 to 73,994,475,560, a change of 20,401,539,240 (38.1%).
- Net income of 3,585,804,450 contributed positively to equity growth.
- Share repurchases of 17,498,831,430 reduced equity.
- New share issuances of 17,498,831,430 increased equity.
- Other factors increased equity by 16,815,734,790.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩3.59 Billion | +4.85% |
| Share Repurchases | ₩17.50 Billion | -23.65% |
| Share Issuances | ₩17.50 Billion | +23.65% |
| Other Changes | ₩16.82 Billion | +22.73% |
| Total Change | ₩- | 38.07% |
Book Value vs Market Value Analysis
This analysis compares NanoenTekInc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.52x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.34x to 1.52x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1046.58 | ₩3495.00 | x |
| 2017-12-31 | ₩969.87 | ₩3495.00 | x |
| 2018-12-31 | ₩1336.88 | ₩3495.00 | x |
| 2019-12-31 | ₩1559.21 | ₩3495.00 | x |
| 2020-12-31 | ₩1697.51 | ₩3495.00 | x |
| 2021-12-31 | ₩1952.98 | ₩3495.00 | x |
| 2022-12-31 | ₩2150.46 | ₩3495.00 | x |
| 2023-12-31 | ₩1999.17 | ₩3495.00 | x |
| 2024-12-31 | ₩2304.40 | ₩3495.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently NanoenTekInc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.85%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.77%
- • Asset Turnover: 0.39x
- • Equity Multiplier: 1.07x
- Recent ROE (4.85%) is above the historical average (-3.91%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -6.94% | -12.64% | 0.45x | 1.22x | ₩-6.01 Billion |
| 2015 | -18.96% | -29.32% | 0.47x | 1.37x | ₩-11.12 Billion |
| 2016 | -57.86% | -66.64% | 0.49x | 1.79x | ₩-17.36 Billion |
| 2017 | -8.73% | -8.70% | 0.56x | 1.79x | ₩-4.45 Billion |
| 2018 | 9.41% | 12.82% | 0.61x | 1.20x | ₩-206.81 Million |
| 2019 | 14.02% | 21.90% | 0.56x | 1.14x | ₩1.65 Billion |
| 2020 | 6.02% | 9.29% | 0.56x | 1.16x | ₩-1.81 Billion |
| 2021 | 13.99% | 20.46% | 0.57x | 1.19x | ₩2.09 Billion |
| 2022 | 8.09% | 13.25% | 0.56x | 1.10x | ₩-1.10 Billion |
| 2023 | -6.86% | -13.71% | 0.46x | 1.09x | ₩-9.04 Billion |
| 2024 | 4.85% | 11.77% | 0.39x | 1.07x | ₩-3.81 Billion |
Industry Comparison
This section compares NanoenTekInc's net assets metrics with peer companies in the Scientific & Technical Instruments industry.
Industry Context
- Industry: Scientific & Technical Instruments
- Average net assets among peers: $95,698,989,173
- Average return on equity (ROE) among peers: -3.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NanoenTekInc (039860) | ₩73.19 Billion | -6.94% | 0.07x | $76.05 Million |
| THINKWARE Corporation (084730) | $181.09 Billion | 1.85% | 0.92x | $55.18 Million |
| Suprema HQ Inc (094840) | $116.87 Billion | 3.22% | 0.07x | $85.79 Million |
| Woojin (105840) | $131.03 Billion | -5.57% | 0.61x | $173.88 Million |
| HyVision System. Inc (126700) | $289.69 Billion | 13.60% | 0.26x | $75.02 Million |
| DAIHAN Scientific Co. Ltd (131220) | $32.63 Billion | 11.55% | 0.68x | $19.67 Million |
| Parksystems Corp (140860) | $26.43 Billion | 14.10% | 0.22x | $1.16 Billion |
| Eugene ACPC SPAC 2 (215090) | $15.75 Billion | -36.71% | 0.41x | $23.38 Million |
| LET co. Ltd (297890) | $30.28 Billion | 24.36% | 0.77x | $79.65 Million |
| Wintec Co. Ltd (320000) | $37.53 Billion | -55.56% | 0.37x | $334.56 Million |
About NanoenTekInc
NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a resid… Read more